COMMUNIQUÉS West-GlobeNewswire

Cedar Park Packs the Parking Lot for Ally Medical ER’s Official Ribbon Cutting
29/10/2026
Neighbors, families, and community leaders filled the parking lot of the newest Ally Medical ER for an evening of food, games, and celebration CEDAR PARK, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency [...]
OSE Immunotherapeutics Reports Additional Positive Results of Combi-TED Phase 2 Randomized Trial with Tedopi® (OSE2101) in metastatic Non-Small Cell Lung Cancer
29/10/2026
Final positive readout for primary and several secondary endpoints presented by Federico Cappuzzo, MD, PhD, on October 25, 2026, at the Annual Meeting of the European Society for Medical Oncology (ESMO) in Madrid 12- [...]
OSE Immunotherapeutics annonce des résultats positifs complémentaires de l'étude de Phase 2 randomisée Combi-TED de Tedopi® (OSE2101) dans le cancer du poumon non à petites cellules métastatique
29/10/2026
Résultats finaux positifs pour le critère principal et plusieurs critères secondaires présentés par le Pr Federico Cappuzzo, PhD, le 25 octobre 2026 au congrès annuel de l’ European Society for Medical Oncology (ESMO) à [...]
Alpha Tau Announces Inclusion in the Flagship TA-90 and TA-125 Indices of the Tel Aviv Stock Exchange
29/10/2026
Funds that track these TASE benchmark indexes are expected to add Alpha Tau shares to their holdings TA-125 tracks the 125 largest and most prominent companies on the TASE JERUSALEM, Oct. 29, 2026 (GLOBE NEWSWIRE) -- [...]
Life with Jan Collaborates with Perrine SDA Church to Bring Renowned Physician Dr. Neil Nedley to South Florida
29/10/2026
Free November 6–7 Community Wellness Seminar Explores Depression, Anxiety, Brain Health, and Cancer Through a Wholistic Approach to Health and Wellbeing Miami, FLORIDA, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Life with Jan, [...]
Retinal Robotics Pioneers Launch VisioSurgical Solutions (VSS) to Bring Compact Surgical Robots to Every Retina Surgeon
29/10/2026
LAUSANNE, Switzerland, Oct. 29, 2026 (GLOBE NEWSWIRE) -- VisioSurgical Solutions (VSS) , a Swiss medical robotics company founded by the team behind the first retinal surgery robot, today announced its launch and the [...]
Trethera Selected as a 2026–2027 National Cancer Institute Investor Showcase Company
29/10/2026
LOS ANGELES, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical-stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, announced today that [...]
Precision Neuroscience Expands Clinical Network Beyond the U.S. with First International Site in Abu Dhabi
29/10/2026
Working with clinical researchers at Cleveland Clinic Abu Dhabi, the brain-computer interface company takes next step toward bringing transformative neurotechnology to patients worldwide NEW YORK, Oct. 29, 2026 (GLOBE [...]
Elicio Therapeutics to Present Phase 2 AMPLIFY-7P Results at the SITC 2026 Annual Meeting
29/10/2026
Keynote/plenary session and late-breaking poster presentation highlight additional data from Phase 2 AMPLIFY-7P trial of camupepimut (ELI-002 7P) in KRAS-mutated pancreatic cancer Additional preclinical poster [...]
Neocis Expands Yomi S® Clearance to Include Pterygoid Implant Placement
29/10/2026
Yomi S receives first and only U.S. FDA clearance for digital guided surgery for pterygoid implants MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Neocis ® , the global leader in robotic-assisted dental surgery announced that [...]
Roivant Social Ventures Announced Support of No Patient Left Behind with Six-Figure Organizational Legacy Gift
29/10/2026
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Today Roivant Social Ventures (RSV) announced it is joining efforts with No Patient Left Behind (NPLB) to improve drug affordability and access while supporting ongoing [...]
Codexis to Report Third Quarter 2026 Financial Results on November 12
29/10/2026
REDWOOD CITY, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced that it [...]
SAB BIO to Host Third Quarter 2026 Financial Results Conference Call and Webcast on November 5, 2026, 08:30 AM ET
29/10/2026
MIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS ), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and [...]
Allogene Therapeutics Announces November Investor Events Highlighting Q3 Results and Initial ALLO-329 Autoimmune Clinical Data
29/10/2026
Q3 2026 Financial Results and Business Update Conference Call and Webcast Scheduled for November 5, 2026 at 2:00 p.m. PT/5:00 p.m. ET ALLO-329 Autoimmune Disease Program Webinar Featuring Preliminary Safety and Efficacy [...]
Milestone Scientific Provides Major Commercial Growth Update as CompuFlo® Expands Across 30 Million+ Annual Global Epidural Procedures
29/10/2026
Company Reports 500+ U.S. Leads, Expanding Healthcare Network Relationships, Federal Market Access, International Distribution and 300+ Issued and Pending Patents Worldwide Just 2% Penetration of Estimated U.S. Epidural [...]
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial Results on Thursday, November 5, 2026
29/10/2026
ASHBURN, Va., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today [...]
Lexicon Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 5, 2026
29/10/2026
THE WOODLANDS, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced the Company will release its third quarter 2026 [...]
Celcuity Schedules Release of Third Quarter 2026 Financial Results and Webcast/Conference Call
29/10/2026
MINNEAPOLIS, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a commercial-stage biotechnology company focused on developing and commercializing targeted therapies for the treatment of multiple solid [...]
Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026
29/10/2026
Presentation will highlight Virtue SAB’s fundamentally different approach of infusing a large liquid volume of proprietary extended-release SirolimusEFR™ directly into and throughout the vessel wall. Virtue SAB’s [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum